FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

2.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

3.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

4.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

5.

Screening tests that are non-invasive show promise in detecting colorectal cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot